Related Experiment Video
Updated: Aug 12, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Reduced G-protein-coupled-receptor kinase 2 activity results in impairment of osteoblast function
M Bliziotes1, M Gunness, X Zhang
1Portland VA Medical Center, Portland, OR 97201, USA. bliziote@ohsu.edu
Abstract:
Rapid phosphorylation of many G-protein-coupled receptors (GPCRs) by G-protein-coupled receptor kinases (GRKs) accompanies stimulus-driven desensitization. Recent evidence suggests that GRKs and their associated arresting proteins, beta-arrestins, function as essential elements in the GPCR-mediated mitogen-activated protein (MAP) kinase signaling cascade. We investigated the interaction between GRKs and MAP kinase activation by growth factors in UMR 106-H5 osteoblastic cells stably expressing a dominant negative mutant of GRK2 (K220R). Expression of K220R in osteoblastic cells results in reduced cellular proliferation, both basally and in response to insulin-like growth factor-1 (IGF-1), and blunting of IGF-1- and EGF-induced MAP kinase activation. Reduced MAP kinase activation is not associated with alterations in IGF-1-receptor autophosphorylation. Both a constitutively active Ras mutant and PMA fully activate MAP kinase in K220R cells. We found that disruption of the GRK2 gene results in: (1) reduced osteoblast proliferation in response to growth factors, and (2) impaired receptor tyrosine kinase activation of mitogenic signaling pathways. Thus, GRK2 may regulate growth factor responsiveness in osteoblasts by modulating multiprotein complex formation following receptor tyrosine kinase activation.
Insights
G-protein-coupled receptor kinase 2 (GRK2) regulates osteoblast proliferation and growth factor signaling. Disrupting GRK2 impairs mitogenic pathways, suggesting its role in receptor tyrosine kinase activation.
Area of Science:
- Cellular Biology
- Molecular Signaling
Background:
- G-protein-coupled receptors (GPCRs) are rapidly phosphorylated by G-protein-coupled receptor kinases (GRKs), leading to desensitization.
- GRKs and beta-arrestins are implicated in GPCR-mediated mitogen-activated protein (MAP) kinase signaling.
Purpose of the Study:
- To investigate the role of GRK2 in MAP kinase activation by growth factors in osteoblastic cells.
- To examine the impact of GRK2 on cellular proliferation and growth factor responsiveness.
Main Methods:
- Utilized UMR 106-H5 osteoblastic cells stably expressing a dominant-negative GRK2 mutant (K220R).
- Assessed cellular proliferation, MAP kinase activation, and insulin-like growth factor-1 (IGF-1) receptor autophosphorylation.
- Investigated the effects of constitutively active Ras mutant and phorbol 12-myristate 13-acetate (PMA).
Main Results:
- Expression of dominant-negative GRK2 (K220R) reduced basal and IGF-1-stimulated osteoblast proliferation.
- K220R expression blunted IGF-1- and epidermal growth factor (EGF)-induced MAP kinase activation without affecting IGF-1 receptor autophosphorylation.
- Disruption of the GRK2 gene impaired receptor tyrosine kinase activation of mitogenic signaling pathways.
Conclusions:
- GRK2 plays a critical role in regulating osteoblast proliferation and responsiveness to growth factors.
- GRK2 modulates multiprotein complex formation downstream of receptor tyrosine kinase activation, impacting mitogenic signaling.
Related Concept Videos
G-protein Coupled Receptors
Osteoclasts in Bone Remodeling
Amplifying Signals via Enzymatic Cascade
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity
Two...

